Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Mario Del Donno"'
Publikováno v:
Multidisciplinary Respiratory Medicine. 18
Idiopathic pulmonary fibrosis (IPF) is a chronic disease with an unknown etiology that causes deterioration of the structure of the lung parenchyma, resulting in a severe and progressive decline in respiratory function and early mortality. IPF is ess
Sleep-disordered breathing (SDB) and obstructive sleep apnea (OSA) are atypical presentation of pituitary adenomas secreting adrenocorticotropic hormone (ACTH) and growth hormone (GH). However, the non-secreting adenomas may cause alterations of slee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9bf2777142a5a88a9ee6aba11693c97
https://doi.org/10.21203/rs.3.rs-137112/v1
https://doi.org/10.21203/rs.3.rs-137112/v1
Autor:
Mariano Mazza, Antonio Di Sorbo, Assunta Micco, Angelo Valerio Romano, Gaetano Beatrice, Mario Del Donno
Publikováno v:
Acute critical care.
Autor:
Mario Del Donno, Isabella Annesi-Maesano, Claudio M. Sanguinetti, Claudio Baccarani, Mario Polverino, Stefano Nardini, Fernando De Benedetto
Publikováno v:
Multidisciplinary Respiratory Medicine
The current SARS-CoV-2 pandemic is still raging in Italy. The country is currently plagued by a huge burden of virus relatedcases and deaths. So far, the disease has highlighted a number of problems, some in common with other Countries and others pec
Autor:
Gaetano Beatrice, Mario Del Donno, Angelo Valerio Romano, Antonio Di Sorbo, Assunta Micco, Mariano Mazza
Publikováno v:
Acute critical care.
Autor:
Antonio Di Sorbo, Gaetano Beatrice, Assunta Micco, Mariano Mazza, Mario Del Donno, Angelo Romano
Publikováno v:
Noninvasive Ventilatory Support.
Recently, high-flow nasal oxygen therapy (HFNO) has been introduced and used in severe ipoxiemic patients or in weaning from invasive ventilation. HFNO is based on an heated and humidified high flow oxygen through a nasal cannula, with an open circui
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Antonio Meriggi, Adriano Berra, Gennaro Liccardi, Emanuela Carpentieri, D. Gargano, Alessandro Vatrella, Bruno Del Prato, Michele Giovannini, F. Gani, Antonio Starace, Mario Lo Schiavo, M. Cutajar, Patrizia Scavalli, Mauro Maniscalco, Maria Giovanna Russo, Ilenia Folletti, Maria D'Amato, Mario Del Donno, Carlo Lombardi, F Madonna, Nicola Scichilone, Anna Agnese Stanziola, Antonio Infantino, G. Baldi, D. Giannattasio, Antonello Salzillo, Manlio Milanese, Gennaro D'Amato, C Montera, A. Pio, Bruno Sposato, Giovanni Passalacqua
Anxiety 34 37 36 Headache 28 23 26 Abdominal pain 1 3 2 Weakness 13 4 9 Depression 5 0 3 Impaired sleep 4 8 7 Nicturia 7 0 5 Chest pain 11 7 9 Excitement 13 6 10 Nonlocalized pain 4 4 4 Hunger 3 4 3 Lack of appetite 5 5 5 Fever 1 3 2 Nausea 1 5 4 Urt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df30268ffe3c0008bbc796d1012efe29
http://hdl.handle.net/11386/4673202
http://hdl.handle.net/11386/4673202
Autor:
Mario Del Donno, Giuseppe Gaudenzi, Diana Radicella, Gaetano Beatrice, Ginevra Del Giudice, Assunta Micco, Mariano Mazza, Andrea Diglio, Angelo Romano
Publikováno v:
1.13 Clinical Problems - Other.
Introduction: Currently there is no consensus on the diagnostic criteria, treatment and follow-up in Pulmonary Sarcoidosis (SP). The purpose of the study was to identify a valid process for the diagnosis of SP. Method: Clinical,radiological and FOB d
Publikováno v:
1.5 Diffuse Parenchymal Lung Disease.
Background: IPF is a chronic,progressive and lethal interstitial lung disease with poor prognosis.Although pirfenidone is tolerable and safe while reducing lung function decline, few studies document the trend of progression in UIP patients before st